Increased plasminogen activator and type IV collagenase activity in invasive follicular thyroid carcinoma cells. Surgery 1995 Dec;118(6):1011-6; discussion 1016-7
Date
12/01/1995Pubmed ID
7491516DOI
10.1016/s0039-6060(05)80107-2Scopus ID
2-s2.0-0028788893 (requires institutional sign-in at Scopus site) 17 CitationsAbstract
BACKGROUND: An essential difference between benign and malignant follicular thyroid tumors is the ability to invade and metastasize. Thyrotropin (TSH) stimulates invasion of cultured human follicular thyroid cancer cells (FTC-133) via a protein kinase C (PKC) dependent mechanism. Tumor invasion depends on degradation of extracellular matrix by proteases.
METHODS: We analyzed protease activity in FTC-133 and its more invasive clone, FTC-238. Cells were treated with TSH or 12-0-tetradecanoyl-phorbol-13-acetate (TPA), a PKC agonist, for 24 hours. Conditioned medium and cellular extract were subjected to substrate gel zymography with either casein-plasminogen or gelatin (collagen). Western blot and immunohistochemistry confirmed protease identity.
RESULTS: We found increased 50 kd urokinase-like plasminogen activator (uPA) and 62 kd gelatinase activity by FTC-238 cells compared with the less invasive FTC-133 cells. There was no effect of TSH on uPA or collagenase activity at concentrations of 0.01 to 10 mU/ml. In both FTC-133 and FTC-238, TPA incubations of 0.1 to 100 ng/ml caused a dose-dependent increase in uPA and a 94 kd type IV collagenase.
CONCLUSIONS: These findings show that TSH-stimulated invasion may be due to PKC-induced activation of uPA and 94 kd type IV collagenase. uPA and basement membrane type IV collagenase warrant investigation as markers for follicular thyroid cancer.
Author List
Packman KS, Demeure MJ, Doffek KM, Wilson SDMESH terms used to index this publication - Major topics in bold
AdenomaCollagenases
Gelatinases
Humans
Neoplasm Invasiveness
Protein Kinase C
Thyroid Neoplasms
Thyrotropin
Tumor Cells, Cultured
Urokinase-Type Plasminogen Activator
